Sanofi-Aventis CEO Chris Viehbacher said Wednesday that he believes his French pharmaceutical company will eventually buy U.S. biotech company Genzyme at a reasonable price. However, he expects it will take some time to agree on a deal, and he won’t rush into anything.
Continue reading Sanofi Is in No Rush to Reach Deal With Genzyme
Sanofi Is in No Rush to Reach Deal With Genzyme originally appeared on DailyFinance on Wed, 15 Sep 2010 09:34:00.
Filed Under: Company News, Health Care, Genzyme Corporation , Sanofi Aventis, Stocks in the News